Michael R. Rickels MD, MS
Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases; Director of Clinical Science, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PennsylvaniaDr. Rickels is the Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases at the University of Pennsylvania Perelman School of Medicine where he serves as Director of Clinical Science in the Division of Endocrinology, Diabetes and Metabolism, Director for Translational Research in the Institute for Diabetes, Obesity & Metabolism, and Medical Director for the Pancreatic Islet Cell Transplant Program.
Dr. Rickels conducts patient-oriented diabetes research that is focused on the physiology of islet function and replacement and glucose counterregulation in defense against hypoglycemia in type 1 diabetes and pancreatogenic forms of diabetes such as cystic fibrosis-related diabetes. This work has been continuously funded by the National Institutes of Health.
Dr. Rickels presently serves as Associate Editor of Diabetes Care and Treasurer-elect for the International Pancreas and Islet Transplant Association.
Disclosures
Dr. Rickels has no relevant conflicts of interest to disclose.Recent Contributions to PracticeUpdate:
- Impact of Insulin Independence Following Islet Transplantation on Long-Term Metabolic Outcomes
- Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes
- Pen-Administered Low-Dose Dasiglucagon vs Usual Care for the Prevention and Treatment of Non-Severe Hypoglycaemia in People With Type 1 Diabetes During Free-Living Conditions
- Association Between the Pancreatic Polypeptide Response and New-Onset Pancreatogenic Diabetes vs Type 2 Diabetes
- Continuous Glucose Monitoring to Assess Glucose Variability in Type 3c Diabetes
- Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Type 1 Diabetes